相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulation of cytokine patterns and microbiome during pregnancy in IBD
Janine van der Giessen et al.
GUT (2020)
Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn's disease: results from two large prospective cohort studies
Hamed Khalili et al.
GUT (2020)
Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease
Charles N. Bernstein et al.
INFLAMMATORY BOWEL DISEASES (2019)
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
Christian Maaser et al.
JOURNAL OF CROHNS & COLITIS (2019)
Key insights from therapeutic drug monitoring in Crohn's disease patients
Margien L. Seinen et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation
Hari K. Somineni et al.
GASTROENTEROLOGY (2019)
Differentiating Crohn's disease from intestinal tuberculosis
Saurabh Kedia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Modulatory Effects of Pregnancy on Inflammatory Bowel Disease
Janine van der Giessen et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses
Daniele Piovani et al.
GASTROENTEROLOGY (2019)
A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015
Sang Hyoung Park et al.
JOURNAL OF CROHNS & COLITIS (2019)
A Review of Dietary Therapy for IBD and a Vision for the Future
Nicole Green et al.
NUTRIENTS (2019)
Detection and management of early stage inflammatory bowel disease: an update for clinicians
Laura Loy et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)
A Simple Fecal Bacterial Marker Panel for the Diagnosis of Crohn's Disease
Songhe Guo et al.
FRONTIERS IN MICROBIOLOGY (2019)
Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
Alessandra Lo Presti et al.
FRONTIERS IN MICROBIOLOGY (2019)
Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses
Sara Vieira-Silva et al.
NATURE MICROBIOLOGY (2019)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb et al.
GUT (2019)
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Bruce E. Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
CD4CD8αα IELs: They Have Something to Say
Chao Zhou et al.
FRONTIERS IN IMMUNOLOGY (2019)
Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms
Julia Pazmandi et al.
IMMUNOLOGICAL REVIEWS (2019)
Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort
Sang Hyoung Park et al.
INFLAMMATORY BOWEL DISEASES (2019)
Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease
Takayuki Imai et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Microbial network disturbances in relapsing refractory Crohn's disease
Bahtiyar Yilmaz et al.
NATURE MEDICINE (2019)
Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study
Yao He et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide population-based study
Hsu-Heng Yen et al.
INTESTINAL RESEARCH (2019)
The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults
Hyo-Jeong Jang et al.
TRANSLATIONAL PEDIATRICS (2019)
Development of an index to define overall disease severity in IBD
Corey A. Siegel et al.
GUT (2018)
Adherent-invasive Escherichia coli in inflammatory bowel disease
Carolina Palmela et al.
GUT (2018)
European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease
Glen Doherty et al.
JOURNAL OF CROHNS & COLITIS (2018)
Environmental triggers in IBD: a review of progress and evidence
Ashwin N. Ananthakrishnan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation
O. O. Moninuola et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease
Josie Libertucci et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
The role of neutrophils in the pathogenesis of Crohn's disease
Anthony W. Segal
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials
Ferdinando D'Amico et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases
Arie Levine et al.
GUT (2018)
Therapeutic Drug Monitoring With Ustekinumab and Vedolizumab in Inflammatory Bowel Disease
Sophie Restellini et al.
INFLAMMATORY BOWEL DISEASES (2018)
Immunochip Meta-Analysis of Inflammatory Bowel Disease Identifies Three Novel Loci and Four Novel Associations in Previously Reported Loci
Myunghee Hong et al.
JOURNAL OF CROHNS & COLITIS (2018)
Comparative Accuracy of Bowel Ultrasound Versus Magnetic Resonance Enterography in Combination With Colonoscopy in Assessing Crohn's Disease and Guiding Clinical Decision-making
Mariangela Allocca et al.
JOURNAL OF CROHNS & COLITIS (2018)
Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease
Phillip Gu et al.
JOURNAL OF DIGESTIVE DISEASES (2018)
Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease
Holm H. Uhlig et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Colorectal Cancer in Inflammatory Bowel Disease
Ryan W. Stidham et al.
CLINICS IN COLON AND RECTAL SURGERY (2018)
Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn's disease
Christopher Ma et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
Arnau Vich Vila et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Emerging concepts in non-invasive monitoring of Crohn's disease
Wojciech Marlicz et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2018)
Functional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiota
Emilie H. Regner et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trial
Matthieu Allez et al.
GUT (2017)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
The genetic background of inflammatory bowel disease: from correlation to causality
Werna T. C. Uniken Venema et al.
JOURNAL OF PATHOLOGY (2017)
The intestinal epithelial barrier: a therapeutic target?
Matthew A. Odenwald et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Value redefined for inflammatory bowel disease patients: a choice-based conjoint analysis of patients' preferences
Welmoed K. van Deen et al.
QUALITY OF LIFE RESEARCH (2017)
Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies
Ronald Ortizo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases
Rupert W. Leong et al.
GASTROENTEROLOGY (2017)
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study
Bruce E. Sands et al.
GASTROENTEROLOGY (2017)
A microbial signature for Crohn's disease
Victoria Pascal et al.
GUT (2017)
Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties
Xin-Lin Chen et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2017)
Development and Validation of a Novel Prediction Model for Differential Diagnosis Between Crohn's Disease and Intestinal Tuberculosis
Jung Ho Bae et al.
INFLAMMATORY BOWEL DISEASES (2017)
Gammadelta T Cells in Crohn's Disease: A New Player in the Disease Pathogenesis?
Ignacio Catalan-Serra et al.
JOURNAL OF CROHNS & COLITIS (2017)
P387 The addition of an immunosuppressant is an effective optimization strategy after loss of response to anti-TNF-alpha monotherapy in patients with inflammatory bowel disease: a two-year experience
F.S. Macaluso et al.
Journal of Crohns & Colitis (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
Fernando Magro et al.
JOURNAL OF CROHNS & COLITIS (2017)
Defective ATG16L1-mediated removal of IRE1α drives Crohn's disease-like ileitis
Markus Tschurtschenthaler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
IKKα controls ATG16L1 degradation to prevent ER stress during inflammation
Michaela A. Diamanti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Intestinal epithelial cell endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammation
Shuhei Hosomi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Jean-Frederic Colombel et al.
LANCET (2017)
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
Brian G. Feagan et al.
LANCET (2017)
Crohn Disease: Epidemiology, Diagnosis, and Management
Joseph D. Feuerstein et al.
MAYO CLINIC PROCEEDINGS (2017)
Fine-mapping inflammatory bowel disease loci to single-variant resolution
Hailiang Huang et al.
NATURE (2017)
Intestinal Behcet and Crohn's disease: two sides of the same coin
Simona Valenti et al.
PEDIATRIC RHEUMATOLOGY (2017)
Diagnosis and management of inflammatory bowel disease in children
Stephanie B. Oliveira et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Diagnosis and management of inflammatory bowel disease in children
Stephanie B. Oliveira et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Preventing disability in inflammatory bowel disease
Patrick B. Allen et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
Innate Lymphoid Cells in Intestinal Inflammation
Alessandra Geremia et al.
FRONTIERS IN IMMUNOLOGY (2017)
Predicting Pre-emptive Discussions of Biologic Treatment: Results from an Openness and Preference Survey of Inflammatory Bowel Disease Patients and Their Prescribers
M. Furaha Kariburyo et al.
ADVANCES IN THERAPY (2017)
Modulation of sphingosine-1-phosphate in inflammatory bowel disease
Laurent Peyrin-Biroulet et al.
AUTOIMMUNITY REVIEWS (2017)
IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease
Lei Zhu et al.
GASTROENTEROLOGY RESEARCH (2017)
A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables
C. A. Siegel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease
S. C. Shah et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease
Ryan Ungaro et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium
Parambir S. Dulai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study
Jee Hye Kwon et al.
GUT AND LIVER (2016)
High Vitamin D-Binding Protein Concentration, Low Albumin, and Mode of Remission Predict Relapse in Crohn's Disease
Simon Ghaly et al.
INFLAMMATORY BOWEL DISEASES (2016)
Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong
Siew C. Ng et al.
INFLAMMATORY BOWEL DISEASES (2016)
Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases
Hans H. Herfarth et al.
INFLAMMATORY BOWEL DISEASES (2016)
Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis
Andrew R. Reinink et al.
INFLAMMATORY BOWEL DISEASES (2016)
Preventing Collateral Damage in Crohn's Disease: The L,mann Index
Gionata Fiorino et al.
JOURNAL OF CROHNS & COLITIS (2016)
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases
Joana Torres et al.
JOURNAL OF CROHNS & COLITIS (2016)
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
Isabelle Cleynen et al.
LANCET (2016)
When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD
Esme van der Gracht et al.
MEDIATORS OF INFLAMMATION (2016)
Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci
David Ellinghaus et al.
NATURE GENETICS (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Antibody markers in the diagnosis of inflammatory bowel disease
Keiichi Mitsuyama et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Serum Albumin and C-Reactive Protein/Albumin Ratio Are Useful Biomarkers of Crohn's Disease Activity
Guangming Qin et al.
MEDICAL SCIENCE MONITOR (2016)
Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease
Tabasum Sidiq et al.
FRONTIERS IN IMMUNOLOGY (2016)
Mechanisms of Quality of Life and Social Support in Inflammatory Bowel Disease
Laura Katz et al.
JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS (2016)
Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China
Gilaad G. Kaplan et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease
E. Safroneeva et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse
Meenakshi Bewtra et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
Jason M. Norman et al.
CELL (2015)
The impact of symptoms, irritable bowel syndrome pattern and diagnostic investigations on the diagnostic delay of Crohn's disease: A prospective study
Giovanni Maconi et al.
DIGESTIVE AND LIVER DISEASE (2015)
Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
Marco Pennazio et al.
ENDOSCOPY (2015)
Interleukin-12 and-23 Control Plasticity of CD127+ Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria
Jochem H. Bernink et al.
IMMUNITY (2015)
Incidence and Natural Course of Inflammatory Bowel Disease in Korea, 2006-2012: A Nationwide Population-based Study
Hyun Jung Kim et al.
INFLAMMATORY BOWEL DISEASES (2015)
Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative
Silvio Danese et al.
JOURNAL OF CROHNS & COLITIS (2015)
Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease
F. Goutorbe et al.
JOURNAL OF CROHNS & COLITIS (2015)
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
Jimmy Z. Liu et al.
NATURE GENETICS (2015)
Commensal bacteria direct selective cargo sorting to promote symbiosis
Qin Zhang et al.
NATURE IMMUNOLOGY (2015)
The global burden of IBD: from 2015 to 2025
Gilaad G. Kaplan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives
Gian Eugenio Tontini et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
Niels Vande Casteele et al.
GUT (2015)
Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific
Siew C. Ng et al.
GUT (2015)
The Role of Thiopurines in Reducing the Need for Surgical Resection in Crohn's Disease: A Systematic Review and Meta-Analysis
Sukhdev Chatu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Catching the Therapeutic Window of Opportunity in Early Crohn's Disease
Silvio Danese et al.
CURRENT DRUG TARGETS (2014)
Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer
Laurent Beaugerie et al.
GUT (2014)
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
Laurent Peyrin-Biroulet et al.
GUT (2014)
Advanced endoscopic imaging techniques in Crohn's disease
Gian Eugenio Tontini et al.
JOURNAL OF CROHNS & COLITIS (2014)
Diagnostic delay in a French cohort of Crohn's disease patients
Stephane Nahon et al.
JOURNAL OF CROHNS & COLITIS (2014)
Natural history and long-term clinical course of Crohn's disease
Hugh James Freeman
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
Lance W. Peterson et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis
Kavinderjit S. Nanda et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation Rate
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Cross-Sectional Imaging Modalities in Crohn's Disease
Mariangela Allocca et al.
DIGESTIVE DISEASES (2013)
Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study
Siew C. Ng et al.
GASTROENTEROLOGY (2013)
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
Jacques Cosnes et al.
GASTROENTEROLOGY (2013)
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
Julian Panes et al.
GASTROENTEROLOGY (2013)
Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
Marte Lie Hoivik et al.
GUT (2013)
Geographical variability and environmental risk factors in inflammatory bowel disease
Siew C. Ng et al.
GUT (2013)
Is Current Smoking Still an Important Environmental Factor in Inflammatory Bowel Diseases? Results from a Population-based Incident Cohort
Peter L. Lakatos et al.
INFLAMMATORY BOWEL DISEASES (2013)
Deletion of Intestinal Epithelial Cell STAT3 Promotes T-Lymphocyte STAT3 Activation and Chronic Colitis Following Acute Dextran Sodium Sulfate Injury in Mice
Tara A. Willson et al.
INFLAMMATORY BOWEL DISEASES (2013)
Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohn's Disease, and Ulcerative Colitis Patients
Scott Plevy et al.
INFLAMMATORY BOWEL DISEASES (2013)
European consensus on the histopathology of inflammatory bowel disease
F. Magro et al.
JOURNAL OF CROHNS & COLITIS (2013)
Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors
Anilga Moradkhani et al.
JOURNAL OF CROHNS & COLITIS (2013)
European evidence based consensus for endoscopy in inflammatory bowel disease
Vito Annese et al.
JOURNAL OF CROHNS & COLITIS (2013)
Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: A prospective population-based study
Zhirong Zeng et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Paneth cells as a site of origin for intestinal inflammation
Timon E. Adolph et al.
NATURE (2013)
Extraintestinal manifestations and complications in IBD
Claudia Ott et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Small-bowel capsule endoscopy: A ten-point contemporary review
Anastasios Koulaouzidis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Study of the Viral and Microbial Communities Associated With Crohn's Disease: A Metagenomic Approach
Vicente Perez-Brocal et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2013)
Meta-analysis: diagnostic medical radiation exposure in inflammatory bowel disease
S. Chatu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion Process
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis A Cohort Study
Ashwin N. Ananthakrishnan et al.
ANNALS OF INTERNAL MEDICINE (2012)
Abnormal Activation of Autophagy-Induced Crinophagy in Paneth Cells From Patients With Crohn's Disease
Elodie Thachil et al.
GASTROENTEROLOGY (2012)
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Edouard Louis et al.
GASTROENTEROLOGY (2012)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber et al.
GUT (2012)
Perianal Crohn's disease findings other than fistulas in a population-based cohort
Laurent Peyrin-Biroulet et al.
INFLAMMATORY BOWEL DISEASES (2012)
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease
Stephan R. Vavricka et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies
Ren Mao et al.
INFLAMMATORY BOWEL DISEASES (2012)
Inflammatory bowel disease in Asia: A systematic review
Lani Prideaux et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne
Lani Prideaux et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
Clinical, serological and genetic predictors of inflammatory bowel disease course
Laurent Beaugerie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease
J. Panes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
Stephan R. Vavricka et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Serum Lipopolysaccharide-binding Protein and Soluble CD14 Are Markers of Disease Activity in Patients with Crohn's Disease
Peter Laszlo Lakatos et al.
INFLAMMATORY BOWEL DISEASES (2011)
Development of the Crohn's Disease Digestive Damage Score, the Lemann Score
Benjamin Pariente et al.
INFLAMMATORY BOWEL DISEASES (2011)
Long-term Complications, Extraintestinal Manifestations, and Mortality in Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
INFLAMMATORY BOWEL DISEASES (2011)
Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+and CD8+human T-cell functional responses
Ritu Sarin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Capsule Endoscopy Has a Significantly Higher Diagnostic Yield in Patients With Suspected and Established Small-Bowel Crohn's Disease: A Meta-Analysis
Paula M. Dionisio et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity
Severine Vermeire et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Paneth cells and innate mucosal immunity
Andre J. Ouellette
CURRENT OPINION IN GASTROENTEROLOGY (2010)
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
Kelvin T. Thia et al.
GASTROENTEROLOGY (2010)
Diagnostic Work-up of Inflammatory Bowel Disease in Children: The Role of Calprotectin Assay
A. Diamanti et al.
INFLAMMATORY BOWEL DISEASES (2010)
Fatigue and Health-related Quality of Life in Inflammatory Bowel Disease: Results from a Population-Based Study in the Netherlands: The IBD-South Limburg Cohort
M. J. L. Romberg-Camps et al.
INFLAMMATORY BOWEL DISEASES (2010)
Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry
Leonardo H. Travassos et al.
NATURE IMMUNOLOGY (2010)
NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation
Rachel Cooney et al.
NATURE MEDICINE (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Impact of pain on health-related quality of life in patients with inflammatory bowel disease
Anja Schirbel et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
Patrick F. van Rheenen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Differential diagnosis of intestinal Behcet's disease and Crohn's disease by colonoscopic findings
S. K. Lee et al.
ENDOSCOPY (2009)
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression
Massimo C. Fantini et al.
GASTROENTEROLOGY (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease
Arthur Kaser et al.
CELL (2008)
Specific gastroduodenoscopic findings in Crohn's disease: Comparison with findings in patients with ulcerative colitis and gastroesophageal reflux disease
M. Kuriyama et al.
DIGESTIVE AND LIVER DISEASE (2008)
Intestinal fibrosis in inflammatory bowel disease - Current knowledge and future perspectives
Florian Rieder et al.
JOURNAL OF CROHNS & COLITIS (2008)
Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation
Christopher R. Weber et al.
LABORATORY INVESTIGATION (2008)
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
Ken Cadwell et al.
NATURE (2008)
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: Meta-analysis of prospective studies
Karin Horsthuis et al.
RADIOLOGY (2008)
Predictors of severe Crohn's disease
Catherine Loly et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Which method is best for imaging of perianal fistula?
Vikram A. Sahni et al.
ABDOMINAL IMAGING (2008)
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
Kathrine Frey Froslie et al.
GASTROENTEROLOGY (2007)
Fibrogenesis in Crohn's disease
John P. Burke et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
Jochen Hampe et al.
NATURE GENETICS (2007)
Adherent-invasive Escherichia coli and Crohn's disease
Nicolas Barnich et al.
CURRENT OPINION IN GASTROENTEROLOGY (2007)
Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease
S. Zeissig et al.
GUT (2007)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology
Holm H. Uhlig et al.
IMMUNITY (2006)
Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs
Kenneth W. Simpson et al.
INFECTION AND IMMUNITY (2006)
Predicting the Crohn's disease activity index from the Harvey-Bradshaw index
WR Best
INFLAMMATORY BOWEL DISEASES (2006)
Oratory markers in IBD: Magic, or unneccessary toys?
S Vermeire et al.
GUT (2006)
Predictors of Crohn's disease
L Beaugerie et al.
GASTROENTEROLOGY (2006)
Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients
DK Amre et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease
K Yamazaki et al.
HUMAN MOLECULAR GENETICS (2005)
Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis
T Bernklev et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
CA Solem et al.
INFLAMMATORY BOWEL DISEASES (2005)
C-reactive protein as a marker for inflammatory bowel disease
S Vermeire et al.
INFLAMMATORY BOWEL DISEASES (2004)
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression
J Wehkamp et al.
GUT (2004)
Inflammatory bowel disease in a Swedish twin cohort:: A long-term follow-up of concordance and clinical characteristics
J Halfvarson et al.
GASTROENTEROLOGY (2003)
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: A prospective study in adults and children
A Carroccio et al.
CLINICAL CHEMISTRY (2003)
Presenting features of inflammatory bowel disease in Great Britain and Ireland
A Sawczenko et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2003)
Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis
Y Ogura et al.
GUT (2003)
The quality of life in patients with Crohn's disease
RD Cohen
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
分享论文
